159 related articles for article (PubMed ID: 19671968)
1. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.
Bednarz B; Hancox C; Xu XG
Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968
[TBL] [Abstract][Full Text] [Related]
2. A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.
Bednarz B; Athar B; Xu XG
Med Phys; 2010 May; 37(5):1987-94. PubMed ID: 20527532
[TBL] [Abstract][Full Text] [Related]
3. Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy.
Hauri P; Schneider U
J Appl Clin Med Phys; 2019 Mar; 20(3):56-70. PubMed ID: 30791198
[TBL] [Abstract][Full Text] [Related]
4. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
5. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validation.
Bednarz B; Xu XG
Phys Med Biol; 2009 Feb; 54(4):N43-57. PubMed ID: 19141879
[TBL] [Abstract][Full Text] [Related]
7. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
10. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies.
Howell RM; Hertel NE; Wang Z; Hutchinson J; Fullerton GD
Med Phys; 2006 Feb; 33(2):360-8. PubMed ID: 16532941
[TBL] [Abstract][Full Text] [Related]
11. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
12. Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer.
Onal C; Arslan G; Parlak C; Sonmez S
Jpn J Radiol; 2014 Apr; 32(4):224-32. PubMed ID: 24510241
[TBL] [Abstract][Full Text] [Related]
13. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
Sethi A; Mohideen N; Leybovich L; Mulhall J
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):970-8. PubMed ID: 12605975
[TBL] [Abstract][Full Text] [Related]
14. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
15. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.
Palma D; Vollans E; James K; Nakano S; Moiseenko V; Shaffer R; McKenzie M; Morris J; Otto K
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):996-1001. PubMed ID: 18455326
[TBL] [Abstract][Full Text] [Related]
16. Neutron dosimetry in organs of an adult human phantom using linacs with multileaf collimator in radiotherapy treatments.
Martinez-Ovalle SA; Barquero R; Gomez-Ros JM; Lallena AM
Med Phys; 2012 May; 39(5):2854-66. PubMed ID: 22559658
[TBL] [Abstract][Full Text] [Related]
17. Dose verification of an IMRT treatment planning system with the BEAM EGS4-based Monte Carlo code.
Francescon P; Cora S; Chiovati P
Med Phys; 2003 Feb; 30(2):144-57. PubMed ID: 12607832
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo simulation of secondary radiation exposure from high-energy photon therapy using an anthropomorphic phantom.
Frankl M; Macián-Juan R
Radiat Prot Dosimetry; 2016 Mar; 168(4):537-45. PubMed ID: 26311702
[TBL] [Abstract][Full Text] [Related]
20. Measurements of non-target organ doses using MOSFET dosemeters for selected IMRT and 3D CRT radiation treatment procedures.
Wang B; Xu XG
Radiat Prot Dosimetry; 2008; 128(3):336-42. PubMed ID: 17627959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
